Cardiva’s vascular closure study shows reductions in bed rest, opioid usage following ablation procedures

A clinical study by Cardiva Medical evaluating its bioabsorbable vascular closure system for electrophysiology procedures met all of its primary and secondary endpoints compared to manual compression, the current standard of care. The company’ s Vascade MVP system���designed for multi-access venous closures, following procedures such as cardiac arrhythmia ablation—demonstrated shorter bed rest times and decreases in the subsequent use of opioid pain medications. The system was able to get patients on their feet nearly four hours faster, on average. The study, which enrolled 204 arrhythmia ablation patients with three or four mid-bore femoral venous access sites, also reduced total post-procedure times, allowing patients to be discharged faster.